Anna Wade, Ph.D.

Anna Wade, Ph.D., is Chief Operating Officer at CoA Therapeutics, where she is responsible for guiding corporate strategy and ensuring the smooth operation of the company. After spending two years as a strategy consultant at L.E.K. consulting, she joined the CoA Therapeutics team and returned to her scientific roots in oncology and neuroscience. Dr. Wade earned a Ph.D. in neuroscience from University College London and served as a post-doctoral researcher in neuro-oncology at the University of California, San Francisco.